Free UK Delivery on orders over £49

Purevax RC 10 dose

Item Number: PUREVAXRC

Purevax RC 10 dose
  • 10 dose

    £ 76.85

    Sorry, this product is not currently available to buy. This is likely because of a manufacturer delay. Call us on 01833 641112 for more information. We may also be able to suggest an alternative.

Total: £0.00

Choose quantity to add to basket



Browse other products from the Boehringer product range


Purevax RC lyophilisate and solvent for suspension for injection.


Lyophilisate and solvent for suspension for injection.

Active substance(s)

Per 1 ml dose:

Freeze-dried pellet:

Attenuated feline rhinotracheitis herpesvirus (FHV F2 strain) = 104.9 CCID50

Inactivated feline calicivirosis antigens (FCV 431 and G1 strains) = 2.0 ELISA U.


Gentamicin, at most 16.5 µg


Water for injections q.s. 1 ml


Active immunisation of cats aged 8 weeks and older against feline viral rhinotracheitis to reduce clinical signs and against calicivirus infection to reduce clinical signs and viral excretion. Onsets of immunity have been demonstrated 1 week after primary vaccination course for rhinotracheitis and calicivirus components.

The duration of immunity is 1 year after the last (re)vaccination.

Dosage and administration

1 ml subcutaneous injection after reconstitution of the freeze-dried pellet with the solvent, according to the following schedule:

Primary vaccination:

First injection: from 8 weeks of age,

Second injection: 3 to 4 weeks later.

Revaccination: Annual.

Where high levels of maternal antibodies against R or C components are expected to be present (e.g. in kittens of 9 - 12 weeks of age born from queens which were vaccinated before pregnancy and/or with known or suspected previous exposure to the pathogen(s)), the primary vaccination course should be delayed until 12 weeks of age.

Contra-indications, warnings, etc

For animal treatment only. Do not use in pregnant animals. Use is not recommended during lactation.

Undesirable effects

Under normal conditions of use, transient apathy and anorexia may occasionally occur, as well as hyperthermia (lasting usually for 1 or 2 days). A local reaction may occur (slight pain at palpation, itching or limited oedema) that disappears within 1 or 2 weeks at most.

In exceptional circumstances a hypersensitivity reaction may occur, which may require appropriate symptomatic treatment.

Special precautions for use

Vaccinate only healthy animals.

Interaction with other veterinary medicinal products and other forms of interaction

Safety and efficacy data are available which demonstrate that this vaccine can be mixed with Merial PUREVAX non-adjuvanted vaccine against feline leukaemia and/or administered the same day but not mixed with Merial adjuvanted vaccine against rabies (RABISIN). Do not mix with any other vaccine or immunological product.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.

Pharmaceutical precautions

Keep out of the reach and sight of children.

Use immediately after reconstitution.

Store and transport at 2°C - 8°C (in a refrigerator), protected from light. Do not freeze.

Dispose of waste material by boiling, incineration or immersion in an appropriate disinfectant approved for use by the competent authorities.

Legal category


Packaging Quantities

10 bottles of 1 dose of lyophilisate and 10 bottles of 1 ml of solvent.

Data Sheets

Purevax Rabies suspension for injection Species:Cats

Therapeutic indication:Immunological veterinary medical products: For cats

Active ingredient:Vaccine Antigens

Product:Purevax Rabies

Product index:Purevax Rabies

Qualitative and quantitative composition

Each dose of 1 ml contains:

Active substance: Rabies recombinant canarypox virus (vCP65) ≥ 106.8 FAID*50

*Fluorescent assay infectious dose 50%

For the full list of excipients, see below.

Pharmaceutical form

Light pink to pale yellow homogeneous suspension for injection.

Clinical particulars

Target species


Indications for use

Active immunisation of cats 12 weeks of age and older to prevent mortality due to rabies infection.

Onset of immunity: 4 weeks after the primary vaccination course.

Duration of immunity after primary vaccination: 1 year.

Duration of immunity after revaccination: 3 years.



Special warnings


Special precautions for use in animals

Vaccinate healthy animals only.

Special precautions to be taken by the person administering the veterinary medicinal product to animals

Canarypox recombinants are known to be safe for humans. Mild local and/or systemic adverse reactions related to the injection itself may be observed transitorily. In case of accidental self-injection, seek medical advice immediately and show the package leaflet or the label to the physician.

Adverse reactions

In very rare cases, transient and slight apathy may occur, as well as mild anorexia or hyperthermia (above 39.5 °C), usually lasting 1 or 2 days. Most of these reactions were noted during the 2 days following the vaccine injection.

A transient local reaction may very rarely occur (pain at palpation, limited swelling that may become nodular, heat at the injection site, and in some cases erythema), that usually disappears within 1 or 2 weeks at most. Very rarely, a hypersensitivity reaction may occur, which may require appropriate symptomatic treatment.

The frequency of adverse reactions is defined using the following convention:

- very common (more than 1 in 10 animals displaying adverse reactions during the course of one treatment)

- common (more than 1 but less than 10 animals in 100 animals)

- uncommon (more than 1 but less than 10 animals in 1,000 animals)

- rare (more than 1 but less than 10 animals in 10,000 animals)

- very rare (less than 1 animal in 10,000 animals, including isolated reports).

Use during pregnancy, lactation or lay

The safety of the veterinary medicinal product has not been established during pregnancy and lactation.


Efficacy data are available which demonstrate that this vaccine can be administered at least 14 days before or after the administration of MERIAL non-adjuvanted vaccine against feline leukaemia.

Safety and efficacy data are available which demonstrate that this vaccine can be mixed and administered with MERIAL non-adjuvanted vaccines containing various combinations of feline viral rhinotracheitis, calicivirosis, panleukopenia and chlamydiosis components.

Amounts to be administered and administration route

Subcutaneous use. Administer one dose of 1 ml according to the following vaccination scheme:

Primary vaccination: 1 injection from 12 weeks of age.

Revaccination: 1 year after primary vaccination, then at intervals of up to 3 years.

Travel to countries requiring a rabies serology test: experience has shown that some vaccinated animals, while protected, may not show the 0.5 IU/ml antibody titre required by some countries. Veterinary surgeons may wish to consider two vaccinations. The best time for a blood sample to be taken is around 28 days after vaccination.


No adverse reactions other than those already mentioned under Adverse reactions have been observed after the administration of 10 doses. The reactions may last longer.

Pharmaceutical particulars


Potassium chloride, Sodium chloride, Potassium dihydrogen phosphate, Disodium phosphate dihydrate, Magnesium chloride hexahydrate, Calcium chloride dihydrate, Water for injections

Major incompatibilities

Do not mix with any other veterinary medicinal product, except those mention under Interactions.

Shelf life

Shelf life of the veterinary medicinal product as packaged for sale: 18 months.

Shelf life after first opening the immediate packaging: use immediately.

Special precautions for storage

Store and transport refrigerated (2 °C – 8 °C). Protect from light. Do not freeze.

Immediate packaging

Box of 2 vials of 1 dose.


Any unused veterinary medicinal product or waste materials derived from such veterinary medicinal products should be disposed of in accordance with the local requirements.

Marketing Authorisation Holder (if different from distributor)

Boehringer Ingelheim Vetmedica GmbH

Binger Strasse 173

55216 Ingelheim am Rhein


Marketing Authorisation Number

UK(GB): Vm 04491/5051

UK(NI): EU/2/10/117/001

Significant changes

Legal category

Legal category:POM-V


GTIN description:Purevax Rabies suspension for injection 2 x 1 dose vials



Shipping charges mainland UK zone1

ValueWeightDelivery Charge
Over £49.00Any WeightFREE
Under £49.00No weight limit£4.50
Under £49.00Under 250g£2.99

Most orders are despatched the same day and standard delivery is 3 to 5 working days from despatch. FAST Expedited options are available.

NB: Orders placed with faster delivery must be placed before 13:00 to ensure same day dispatch (excluding weekends and bank holidays). Please also check on the product page that the items ordered show 'In Stock' otherwise your order will be delayed until the stock becomes available, which in most cases will only be 24hrs.

Estimated "Usually shipped in" information is shown against most products

Overseas orders

Postage outside of the UK is from £4.50

Prescription Items

Prescription items will be sent on receipt of a valid signed and dated prescription.

Pick up

We offer a pickup service for orders placed over the phone.

Please ring us on 01833 641112 for more information.

Refrigerated Items

Refrigerated items will be sent by carrier or Royal Mail with coolpacks unless you pay for a premium for a refrigerated delivery. We will contact you prior to despatch for your instructions.


We want you to be completely satisfied with any purchase. If not any item* can be returned to us within 14 days of receipt for exchange or refund Please give us a ring for a returns number on 01833 641112 or alternatively email [email protected] to obtain a returns number.

*Due to legal requirements medicines may not be returned except to correct an error in despatch or in response to an "official recall". If an item is believed to be faulty it should be returned for inspection and it may be necessary to forward it to the manufacturers for testing before replacements or refunds can be authorised. This does not infringe legal rights. Please contact our customer services for a "Returns Number" which must appear on the outside of the package or it will not be accepted. We advise customers to use an insured method of shipping and to retain proof of despatch. We may refuse returns on products specially obtained or manufactured to order. Items must be returned unsoiled and unused and sent adequately packed and carriage paid.

Frequently Asked Questions

There have been no questions/answers for this product so far.

Ask Question

Ask a question about Purevax RC 10 dose


There have been no reviews for this product.